SAN ANTONIO--(BUSINESS WIRE)--Vidacare Corporation has released an interim analysis of the validation study on its OnControl™ Bone Marrow System, the first effort in decades to improve the safety, control, and comfort of bone marrow aspiration and biopsy procedures. The validation study’s endpoints included successful sample acquisition, quality of sample, ease of use, and overall user satisfaction. Based on the positive results of this interim analysis, Vidacare is offering a limited commercial release of the product on July 27, with a full-scale commercial launch in the 3rd and 4th quarters of 2009.
